Events

EIT water: deep dive into the evaluation process
MAY
Wed
07
10:00 - 12:00

This was 8 months ago

Location

online

Programmes
Agro-Food, Environment EIT

At the beginning of the year, The European institute of innovation and technology (EIT) launched the call for a new EIT Knowledge and Innovation Community (KIC) in the water, marine and maritime sectors and ecosystems. A KIC is a community thet brings together people from the world of business, universities and research institutions. It will address global challenges including: water scarcity, droughts and floods as well as marine and freshwater degradation. 

Although the call is still open, The people at the EIT already want to provide a deep inisght into the evaluation process. This will take place online on the 7th of May in the morning. You can find all the details on this webpage

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.